Last reviewed · How we verify

NCT06184620

Correlation Between Angle Closure Glaucoma Data and Lens Zonule Status

Completed Last updated 28 December 2023
What this trial tests

trial in Primary Angle Closure Glaucoma in 263 participants. Completed in 30 March 2023.

Timeline
1 December 2020
Primary endpoint
30 March 2023
30 March 2023

Quick facts

Lead sponsorGuangfu Dang
StatusCompleted
Study typeOBSERVATIONAL
Enrollment263
Start date1 December 2020
Primary completion30 March 2023
Estimated completion30 March 2023
Sites1 location across China

Conditions studied

Sponsor

Guangfu Dang

Who can join

Adults 47 to 91, any sex, with Primary Angle Closure Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to discuss the correlation between primary angle-closure glaucoma and the state of the suspended ligament of the lens and the pathogenesis of PACG by measuring the biological data of primary angle-closure glaucoma and observing its anatomical changes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Primary Angle Closure Glaucoma

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06184620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing